Clinical trial
Effectiveness of Eplerenone to Improve Target Organ Damage in Patients With…
NCT00138944 · University of Erlangen-Nürnberg Medical School, Other · Completed
Key facts
| NCT number | NCT00138944 |
|---|---|
| Title | Effectiveness of Eplerenone to Improve Target Organ Damage in Patients With Resistant Arterial Hypertension |
| Official title | Effectiveness of Eplerenone to Improve Target Organ Damage in Patients With Resistant Arterial Hypertension |
| Lead sponsor | University of Erlangen-Nürnberg Medical School, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Essential Hypertension |
| Intervention type | Drug |
| Interventions | placebo, eplerenone |
| Enrollment | 85 |
| Start date | Jan 1, 2007 |
| Primary completion | May 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | Aug 30, 2005 |
| Last update posted | Apr 17, 2013 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: